ONGENTYS: payments to doctors
Payments that named ONGENTYS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3M
- Providers
- 7,958
- Transactions
- 46,256
- Average per transaction
- $64
The per-transaction average — $64 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,958 providers the average total is $374, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Neurocrine Biosciences, Inc. | $2,568,410 | 86.3% |
| Amneal Pharmaceuticals LLC | $406,881 | 13.7% |